Biotech has quietly taken over as market leader heading into H2, with an unusually high share of the sector sitting in top short-term momentum right now. Midterm-year data historically favors healthcare names into the second half, and Friday's unusual flow flagged notable healthcare positioning on top of that. Worth getting a watchlist together if you've been away from the sector.
Aggregated and distilled by Two Sentence Traders. Not financial advice.